• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Hydroxychloroquine, Coronavirus Disease 2019, and QT Prolongation.

作者信息

Bonow Robert O, Hernandez Adrian F, Turakhia Mintu

机构信息

Northwestern University Feinberg School of Medicine, Chicago, Illinois.

Editor, JAMA Cardiology.

出版信息

JAMA Cardiol. 2020 Sep 1;5(9):986-987. doi: 10.1001/jamacardio.2020.1782.

DOI:10.1001/jamacardio.2020.1782
PMID:32936259
Abstract
摘要

相似文献

1
Hydroxychloroquine, Coronavirus Disease 2019, and QT Prolongation.羟氯喹、2019冠状病毒病与QT间期延长
JAMA Cardiol. 2020 Sep 1;5(9):986-987. doi: 10.1001/jamacardio.2020.1782.
2
Experience of short-term hydroxychloroquine and azithromycin in COVID-19 patients and effect on QTc trend.新冠病毒肺炎患者短期使用羟氯喹和阿奇霉素的经验及其对QTc趋势的影响
J Infect. 2020 Aug;81(2):e117-e119. doi: 10.1016/j.jinf.2020.05.058. Epub 2020 May 28.
3
Hydroxychloroquine for Covid-19 - When the pandemic runs faster than research.用于治疗新冠病毒病的羟氯喹——当疫情发展速度超过研究速度时
Int J Cardiol. 2020 Oct 1;316:285-286. doi: 10.1016/j.ijcard.2020.05.079. Epub 2020 May 29.
4
Assessment of QT Intervals in a Case Series of Patients With Coronavirus Disease 2019 (COVID-19) Infection Treated With Hydroxychloroquine Alone or in Combination With Azithromycin in an Intensive Care Unit.评估单独使用羟氯喹或联合使用阿奇霉素在重症监护病房治疗的 2019 年冠状病毒病（COVID-19）感染患者的 QT 间期。
JAMA Cardiol. 2020 Sep 1;5(9):1067-1069. doi: 10.1001/jamacardio.2020.1787.
5
Azithromycin and SARS-CoV-2 infection: Where we are now and where we are going.阿奇霉素与 SARS-CoV-2 感染：我们现在在哪里，以及我们将走向何方。
J Glob Antimicrob Resist. 2020 Sep;22:680-684. doi: 10.1016/j.jgar.2020.06.016. Epub 2020 Jul 1.
6
Hydroxychloroquine and azithromycin as a treatment of COVID-19.羟氯喹和阿奇霉素作为新型冠状病毒肺炎的一种治疗方法。
Intern Emerg Med. 2020 Aug;15(5):841-843. doi: 10.1007/s11739-020-02388-y. Epub 2020 May 30.
7
Hydroxychloroquine-azithromycin for COVID-19 - Warranted or dangerous?用于治疗COVID-19的羟氯喹啉-阿奇霉素——合理还是危险？
Travel Med Infect Dis. 2020 May-Jun;35:101764. doi: 10.1016/j.tmaid.2020.101764. Epub 2020 May 30.
8
No evidence of clinical benefits of early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: Comment on "Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France".没有证据表明用羟氯喹和阿奇霉素对新冠病毒疾病患者进行早期治疗有临床益处：对《用羟氯喹和阿奇霉素对新冠病毒疾病患者进行早期治疗：法国马赛1061例回顾性分析》的评论
Travel Med Infect Dis. 2020 Jul-Aug;36:101819. doi: 10.1016/j.tmaid.2020.101819. Epub 2020 Jul 3.
9
Response to the editorial "COVID-19 in patients with cardiovascular diseases": Covid-19 treatment with hydroxychloroquine or chloroquine and azithromycin: A potential risk of Torsades de Pointes.对社论《心血管疾病患者的COVID-19》的回应：使用羟氯喹或氯喹及阿奇霉素治疗COVID-19：尖端扭转型室速的潜在风险。
Arch Cardiovasc Dis. 2020 May;113(5):367-368. doi: 10.1016/j.acvd.2020.04.001. Epub 2020 Apr 15.
10
Safe use of hydroxychloroquine and its combination with azithromycin in the context of Sars-CoV-2 outbreak: Clinical experience in a Belgian tertiary center.在新型冠状病毒肺炎疫情背景下羟氯喹及其与阿奇霉素联合使用的安全性：比利时一家三级中心的临床经验
Travel Med Infect Dis. 2020 Jul-Aug;36:101788. doi: 10.1016/j.tmaid.2020.101788. Epub 2020 Jun 12.

引用本文的文献

1
Remdesivir-Associated Significant Bradycardia: A Report of Three Cases.瑞德西韦相关的显著心动过缓：三例报告
J Tehran Heart Cent. 2021 Apr;16(2):79-83. doi: 10.18502/jthc.v16i2.7390.
2
Pharmacological basis for the potential role of Azithromycin and Doxycycline in management of COVID-19.阿奇霉素和多西环素在新冠病毒疾病管理中潜在作用的药理学基础。
Arab J Chem. 2021 Mar;14(3):102983. doi: 10.1016/j.arabjc.2020.102983. Epub 2021 Jan 10.
3
Effect of Hydroxychloroquine on QTc in Patients Diagnosed with COVID-19: A Systematic Review and Meta-Analysis.
羟氯喹对确诊为COVID-19患者QTc的影响：一项系统评价和荟萃分析
J Cardiovasc Dev Dis. 2021 May 13;8(5):55. doi: 10.3390/jcdd8050055.
4
Chemoprophylaxis trial designs in epidemics: insights from a systematic review of COVID-19 study registrations.传染病化学预防试验设计：从 COVID-19 研究注册的系统评价中得到的启示。
Trials. 2021 May 29;22(1):370. doi: 10.1186/s13063-021-05323-4.
5
Cytotoxicity Evaluation of Chloroquine and Hydroxychloroquine in Multiple Cell Lines and Tissues by Dynamic Imaging System and Physiologically Based Pharmacokinetic Model.通过动态成像系统和基于生理的药代动力学模型评估氯喹和羟氯喹在多种细胞系和组织中的细胞毒性
Front Pharmacol. 2020 Nov 20;11:574720. doi: 10.3389/fphar.2020.574720. eCollection 2020.
6
Expert Opinions on the Most Promising Treatments and Vaccine Candidates for COVID-19: Global Cross-sectional Survey of Virus Researchers in the Early Months of the Pandemic.专家对 COVID-19 最有前途的治疗方法和疫苗候选物的意见：大流行早期对病毒研究人员的全球横断面调查。
JMIR Public Health Surveill. 2021 Feb 26;7(2):e22483. doi: 10.2196/22483.
7
Of mice, microglia, and (wo)men: a case series and mechanistic investigation of hydroxychloroquine for complex regional pain syndrome.小鼠、小胶质细胞与人类：羟氯喹治疗复杂性区域疼痛综合征的病例系列及机制研究
Pain Rep. 2020 Aug 25;5(5):e841. doi: 10.1097/PR9.0000000000000841. eCollection 2020 Sep-Oct.
8
Hydroxychloroquine as a Chemoprophylactic Agent for COVID-19: A Clinico-Pharmacological Review.羟氯喹作为COVID-19的化学预防剂：临床药理学综述
Front Pharmacol. 2020 Dec 17;11:593099. doi: 10.3389/fphar.2020.593099. eCollection 2020.
9
Randomized double-blinded placebo-controlled trial of hydroxychloroquine with or without azithromycin for virologic cure of non-severe Covid-19.羟氯喹啉联合或不联合阿奇霉素用于非重症新型冠状病毒肺炎病毒学治愈的随机双盲安慰剂对照试验
EClinicalMedicine. 2020 Dec;29:100645. doi: 10.1016/j.eclinm.2020.100645. Epub 2020 Nov 20.
10
Electrical storm in a patient with COVID-19 treated with hydroxychloroquine: A case report.一名接受羟氯喹治疗的新冠肺炎患者发生电风暴：病例报告
SAGE Open Med Case Rep. 2020 Nov 16;8:2050313X20974217. doi: 10.1177/2050313X20974217. eCollection 2020.